Boehringer, Zealand Begin Phase III Program For Obesity Contender Survodutide

Studies Include Cardiovascular Outcomes Trial

Nutritionist sitting at her desk
The three-trial Phase III program will begin enrolling patients soon • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Clinical Trials

More from R&D